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Degradation of cellular proteins by the proteasome is
critical for the generation of MHC-associated peptides.
The constitutive proteasome and the IFNg-induced
immunoproteasome (IP) differ in the use of three cataly-
tic b subunits, which alters production of MHC class I
epitopes. The potential for a disparate repertoire of epi-
topes produced between inflammatory/non-inflammatory
tumours therefore arises.
We have extensively investigated this phenomenon both
broadly, in terms of the cancer cell as a whole, and specifi-
cally, by evaluating presentation of three NY-ESO-1 HLA-
Cw3 restricted epitopes.
We profiled the immunopeptidome of a melanoma cell
line under steady state or IFNg-treated conditions;
by mass spectrometry analysis of HLA Class I bound
peptides. Profound changes in the overall epitope profile
presented on HLA Class I molecules, leading to extensive
alteration in the overall immunogenicity of the cell, were
observed.
We studied processing and presentation of three NY-
ESO-1 HLA-Cw3 restricted epitopes by melanoma cell
lines. Using specific T-lymphocyte clones, we examined
presentation of each epitope following processing through
proteasome subtypes. We further investigated processing
of these epitopes by selective inhibition of the IP catalytic
subunit LMP7 by siRNA knockdown, or small molecule
inhibition.
In vivo, we demonstrate that melanoma cells can be
induced to switch proteasome subtype following treat-
ments which induce IFNg at the tumour site.
Our data demonstrate broad changes in epitopes pre-
sented by melanoma cells under inflammatory versus
non-inflammatory conditions. These results illustrate a
little-studied mechanism of immune escape by tumour
cells. Awareness of how individual cancer epitopes are
processed by melanoma cells is therefore critical to
inform development of future therapies which involve
cancer vaccination, adoptive T-lymphocyte transfer, or
combination treatments including these.
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